Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Trading Statement

11 Nov 2015 07:00

RNS Number : 2597F
Exova Group PLC
11 November 2015
Β 

11 November 2015

Exova Group plc

Trading Update

Organic growth on track and acquisitions performing to planΒ 

Exova Group plc ("Exova"), a leading international provider of technically demanding testing, certification and advisory services, today releases a Trading Update for the period since 30 June 2015 to date. Where stated, financial results are for the period from 1 January to 31 October 2015 compared with the corresponding period in 2014.

Group performance for the ten months to 31 October 2015

Β 

Β· Revenue up 9.3% at constant currency; 7.5% at actual rates

o 2.7% organic growth at constant currency (7.6% excluding Oil & Gas and Industrials)

o 6.6% growth from M&A activity

Β· BM TRADA acquisition integrating well and performing in line with expectations

Β· M&A pipeline continues to be strong

Β· Outlook for 2015 earnings remains unchanged

Regional performance in the period from 1 July 2015 to date

Β 

In Europe, we saw good organic growth in our Health Sciences and Product & Certification clusters. The integration of BM TRADA, which we acquired in May this year, has gone well and the business is on track to deliver in line with expectations for 2015 and to realise the planned synergies in 2016. As expected, the impact of low oil prices has led to further contraction and price pressure in our Oil & Gas and Industrials cluster.

Organic revenues in the Americas have improved as we continued to see good progress in the Aerospace and Transportation sectors. Our Oil & Gas and Industrials cluster has experienced similar headwinds to Europe.

Β 

In Rest of World, strong growth has continued in the Middle East and the pipeline of new contracts looks strong into 2016.

We have continued to take restructuring actions across the Group to mitigate the impact on margin where we face market headwinds.

Outlook

Β 

The Board confirms previous guidance for full year earnings in 2015. Restructuring costs will also be in line with expectations.

Β 

Ian El-Mokadem, Chief Executive Officer, commented:

Β 

"I am pleased with our overall performance for the year to date. We have seen good growth in most of our sectors and are making very good progress with acquisitions."

Β 

Full year results

The Group's full year results to 31 December 2015 will be announced on 2 March 2016.

Β 

Contacts

Β 

Ian Middleton / Sophie Moate

Powerscourt Group

Tel. Direct +44 (0)20 7250 1446 / +44 (0)7885 508 527

exova@powerscourt-group.com

Β 

Ian Power, Investor Relations

Exova Group plc

Telephone: +44 (0) 131 476 7619

investor.relations@exova.com

Β 

Β 

About Exova

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK Exova operates 143Β laboratories and offices in 32 countries and employs around 4,500 people throughout Europe, the Americas, the Middle East and Asia/Asia Pacific.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors from health sciences to aerospace, transportation, oil and gas, fire and construction.

This Trading Update release contains forward-looking statements that involve substantial risks and uncertainties and actual results and developments may differ materially from those expressed or implied by these statements by a variety of factors. These forward-looking statements speak only as at the date of this press release. In addition, all projections, valuations and statistical analyses provided in this document may be based on unaudited pro-forma financial information, subjective assessments and assumptions. They may use alternative methodologies that produce different results and should not be relied upon as an accurate prediction of future performance.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTPKKDNOBDDQDD
Date   Source Headline
28th Mar 201711:45 amRNSForm 8.5 (EPT/RI) Exova Group Plc
28th Mar 201711:16 amRNSForm 8.5 (EPT/RI)
28th Mar 201711:00 amRNSForm 8.5 (EPT/RI)
28th Mar 201710:33 amRNSForm 8.3 - Exova Group plc
28th Mar 20177:00 amBUSForm 8.3 - Exova Group Plc
27th Mar 20173:12 pmBUSForm 8.3 - Exova Group Plc
27th Mar 20173:05 pmRNSForm 8.3 - Exova Group Plc
27th Mar 201710:37 amRNSForm 8.3 - Exova Group PLC
27th Mar 20179:15 amRNSRule 2.9 Announcement
27th Mar 20177:00 amRNSPossible Offer for Exova Group plc
28th Feb 20177:00 amRNSFinal Results
12th Jan 20177:00 amRNSPost-close Trading Update
21st Dec 201612:06 pmRNSChanges to Nomination Committee
6th Dec 20167:02 amRNSDevelopment of global laboratory portfolio
1st Dec 20163:15 pmRNSVoting Rights and Capital
29th Nov 20169:00 amRNSDirector/PDMR Shareholding
24th Nov 20169:00 amRNSIssue of Equity
24th Nov 20169:00 amRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSDivisional Reporting of Historic Results
24th Nov 20167:00 amRNSTrading Statement
27th Oct 20164:35 pmRNSPrice Monitoring Extension
24th Oct 20168:51 amRNSTR-1: Notification of Major Interest in Shares
21st Oct 20169:27 amRNSTR-1: Notification of Major Interest in Shares
4th Oct 20164:35 pmRNSPrice Monitoring Extension
21st Sep 20167:00 amRNS2016 Capital Markets Day
13th Sep 20169:00 amRNSTR-1: Notification of Major Interest in Shares
31st Aug 20167:00 amRNSHalf-year Report
21st Jul 20164:40 pmRNSSecond Price Monitoring Extn
21st Jul 20164:35 pmRNSPrice Monitoring Extension
4th Jul 20167:00 amRNSExova acquires Jones Environmental Forensics
1st Jul 20167:00 amRNSExova completes sale of Food, Water & Pharma Biz
29th Jun 20163:07 pmRNSNotice of Results and Capital Markets Day
28th Jun 20164:40 pmRNSSecond Price Monitoring Extn
28th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20168:00 amRNSDirector Declaration
19th May 20161:46 pmRNSResult of AGM
19th May 20161:39 pmRNSAGM Statement
19th May 20167:00 amRNSExova sells UK & Ire Food, Water & Pharma Business
19th May 20167:00 amRNSTrading Update
10th May 20169:00 amRNSDirector/PDMR Shareholding
5th May 201610:00 amRNSIssue of Equity
5th May 201610:00 amRNSDirector/PDMR Shareholding
22nd Apr 20162:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Apr 20162:00 pmRNSDirector/PDMR Shareholding
11th Apr 20169:43 amRNSAnnual Report & Accounts 2015 & Notice of 2016 AGM
1st Apr 20169:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
9th Mar 20169:00 amRNSDirector/PDMR Shareholding
7th Mar 20169:00 amRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSFinal Results
18th Feb 201610:16 amRNSDisclosure of Home Member State

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.